Rejuvii IV Therapy & Wellness
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Migraine Treatment
Arlington Heights, IL
Arlington Heights sits in Cook County northwest of Chicago, a mature suburb of roughly 77,000 near O'Hare International Airport and the former Arlington International Racecourse property being redeveloped by the Chicago Bears. The local IV therapy market serves a mix of O'Hare-based flight crews and consultants, retirees, and families in neighborhoods like Stonegate and Scarsdale. Clinics cluster along Arlington Heights Road, Rand Road, and near Northwest Community Hospital. Illinois Department of Financial and Professional Regulation rules allow RNs to place peripheral IVs under physician delegation, and Illinois APRNs can attain full practice authority under the Nurse Practice Act. Cold Midwestern winters drive vitamin D and immune demand, and mobile service serves Palatine, Mount Prospect, and Buffalo Grove, with jet lag recovery making up a distinctive piece of the O'Hare-adjacent market.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Illinois medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.